Literature DB >> 2737612

An immunohistological and genotypic study of the plasma cell form of Castleman's disease.

P A Hall1, M Donaghy, F E Cotter, A G Stansfeld, D A Levison.   

Abstract

The plasma cell variant of Castleman's disease (angiofollicular hyperplasia) is an uncommon and poorly understood lymphoproliferative disorder which may be associated with a wide variety of systemic features. The clinical, pathological, immunophenotypic and genotypic features of a series of five cases are presented. The clinical manifestations were variable but systemic features were present in four cases. Histologically, all five cases were similar. The characteristic follicle-like structures are composed of concentric rings of B-lymphocytes with a mantle zone phenotype, surrounding an inner core of dendritic reticulum cells. The central regions are composed of plump cells that express Factor VIII related antigen, stain with Ulex europaeus I and are associated with laminin immunoreactivity. Many of these cells stain with Ki67 indicating cellular proliferation. Between these 'follicles', plasma cells are present interspersed between high endothelial venules. Using immunohistochemical techniques two cases were polyclonal, whilst in two others unequivocal lambda/IgA restriction was present; in the other case an intermediate picture of lambda/IgA predominance was apparent. Genotypic studies in three cases indicated immunoglobulin gene rearrangements but germ line T-cell receptor genes. The significance of the apparent clonal proliferation of plasma cells is discussed and a unifying model of Castleman's disease is proposed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2737612     DOI: 10.1111/j.1365-2559.1989.tb02162.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  15 in total

Review 1.  NF-κB as a target for oncogenic viruses.

Authors:  Shao-Cong Sun; Ethel Cesarman
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

2.  Nodal and extranodal plasmacytomas expressing immunoglobulin a: an indolent lymphoproliferative disorder with a low risk of clinical progression.

Authors:  Haipeng Shao; Liqiang Xi; Mark Raffeld; Stefania Pittaluga; Kieron Dunleavy; Wyndham H Wilson; Nelson Spector; Cristiane Milito; Jose Carlos Morais; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2010-10       Impact factor: 6.394

Review 3.  Multicentric Castleman disease: Where are we now?

Authors:  Hao-Wei Wang; Stefania Pittaluga; Elaine S Jaffe
Journal:  Semin Diagn Pathol       Date:  2016-05-16       Impact factor: 3.464

Review 4.  HIV-associated multicentric Castleman disease.

Authors:  Deepa Reddy; Ronald Mitsuyasu
Journal:  Curr Opin Oncol       Date:  2011-09       Impact factor: 3.645

5.  Morpho-immunophenotypic diversity of Castleman's disease, hyaline-vascular type: with emphasis on a stroma-rich variant and a new pathogenetic hypothesis.

Authors:  A D Danon; J Krishnan; G Frizzera
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

6.  Cellular localisation of HHV-8 in Castleman's disease: is there a link with lymph node vascularity?

Authors:  J O'Leary; M Kennedy; D Howells; I Silva; V Uhlmann; K Luttich; S Biddolph; S Lucas; J Russell; N Bermingham; M O'Donovan; M Ring; C Kenny; M Sweeney; O Sheils; C Martin; S Picton; K Gatter
Journal:  Mol Pathol       Date:  2000-04

Review 7.  Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis.

Authors:  Kwun Wah Wen; Blossom Damania
Journal:  Cancer Lett       Date:  2009-08-03       Impact factor: 8.679

8.  Intracranial Castleman's disease presenting as hypopituitarism.

Authors:  L T Ribeiro; G N Simão; A L M Matos; C G Carlotti; B O Colli; L Neder; A Ribeiro-Silva; M de Castro; E Rego; Antônio Carlos Santos
Journal:  Neuroradiology       Date:  2004-10       Impact factor: 2.804

9.  Increased CD5-positive polyclonal B cells in Castleman disease: a diagnostic pitfall.

Authors:  Qingyan Liu; Stefania Pittaluga; Theresa Davies-Hill; Mark Raffeld; Liqiang Xi; Elaine S Jaffe
Journal:  Histopathology       Date:  2013-08-19       Impact factor: 5.087

10.  Increased interleukin-6 (IL-6) production in a young child with clinical and pathologic features of multicentric Castleman's disease.

Authors:  M C Kinney; D S Hummell; P M Villiger; A Hourigan; L Rollins-Smith; A D Glick; A R Lawton
Journal:  J Clin Immunol       Date:  1994-11       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.